Advertisement

Suppression of Bronchial Response to Platelet Activating Factor Following Taurine Administration

  • Michio Kurachi
  • Kayoko Hongoh
  • Akiko Watanabe
  • Hironaka Aihara
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 217)

Abstract

Platelets contain a high level of taurine (10), and accumulate this neutral amino acid by an energy-dependent process (7). Taurine inhibits the aggregation induced by ADP (1), and hence is thought to modulate the platelet function.

Keywords

Rabbit Platelet Bath Fluid Bronchial Response Bronchial Tone Creatinine Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Almazov, V.A., Gurerich, V.S., Mikhailova, I.A., and Streltaova, E.N., 1985, The influence of taurine on Ca2+, Mg2+, ATPase activity and aggregation of human platelet (Russian), Byull. Ekap. Biol. Med., 100:398–400.Google Scholar
  2. 2.
    Bennett, J., Thibaudeau, D., and Bessin, P., 1983, Dependency of the PAF-acether induced bronchospasm on the lipoxygenase pathway in the guinea pig, Prostaglandins, 26:457–466.CrossRefGoogle Scholar
  3. 3.
    Chignard, M., LeCouedic, J.P., Tence, M., Vargaftig, B.B., and Benveniste, J., 1979, The role of platelet-activating factor in platelet aggregation, Nature, 279:799–800.PubMedCrossRefGoogle Scholar
  4. 4.
    Darius, H., Lefer, D.J., Smith, J.B., and Lefer, A.M., 1986, Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis, Science, 232:58–60.PubMedCrossRefGoogle Scholar
  5. 5.
    Demopoulos, C.A., Pinckard, R.N., and Hanahan, D.J., 1979, Platelet activating factor. Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators), J. Biol. Chem., 254:9355–9358.PubMedGoogle Scholar
  6. 6.
    Fitzgerald, M.F., Moncada, S., and Parente, L., 1986, The anaphylactic release of platelet-activating factor from perfused guinea pigs, Br. J. Pharmac., 88:149–153.CrossRefGoogle Scholar
  7. 7.
    Gaut, Z.N., and Nauss, C.B., 1976, Uptake of taurine by human blood platelets: A plssible model for brain, in: “Taurine”, R. J. Huxtable and A. Barbeau eds., Raven Press, New York, pp. 91–98.Google Scholar
  8. 8.
    Hwang, S., Lam, M., Li, C, and Shen, T., 1986, Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema, Eur. J. Pharmac., 120:33–41.CrossRefGoogle Scholar
  9. 9.
    Inarrea, P., Gomez-Cambronero, J., Nieto, M., and Crespo, M.S., 1984, Characteristics of the binding of platelet-activating factor to platelets of different animal species, Eur. J. Pharmac, 105:309–315.CrossRefGoogle Scholar
  10. 10.
    Jacobsen, J.G., and Smith, L.H., 1968, Biochemistry and physiology of taurine and taurine derivatives, Physiol. Rev., 48:424–511.PubMedGoogle Scholar
  11. 11.
    Konzett, H., and Rossler, R., 1940, Verschsanordnung zu Utersuchungen an der Bronchialmuskulatur, Naunyn-Schmiedebergs Arch. Exp. Path. Pharmak., 195:71.CrossRefGoogle Scholar
  12. 12.
    Lee, T-C., Mlone, B., Blank, M.L., and Snyder, F., 1981, l-Alkyl 2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelet, Biochem. Biophys. Res. Commun., 102:1262–1268.PubMedCrossRefGoogle Scholar
  13. 13.
    Maridonneau-Parini, I., Lagente, V., Lefort, J., Russo-Marie, F., and Vargaftig, B.B., 1985, Desensitization to PAF-induced bronchoconstriction and to activation of th alveolar macrophages by repeated inhalations of PAF in the guinea pig, Biochem. Biophys. Res. Commun., 131:42–49.PubMedCrossRefGoogle Scholar
  14. 14.
    Namm, D.H., Tadepalli, A.S., and High, J.A., 1982, Species specificity of the platelet responses to l-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine, Thromb. Res., 25:341–350.PubMedCrossRefGoogle Scholar
  15. 15.
    Robertson, D.N., and Smith, G.M., 1986, Cv88 inhibits in vivo platelet aggregation induced by PAF-acether and collagen, Eur. J. Pharmac, 123:91–97.CrossRefGoogle Scholar
  16. 16.
    Shaw, J.O., Klusick, S.J., and Hanahan, D.J., 1981, Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-0-hexadecy1/-octadecyl-2-acetyl-2-sn-glyceryl-3-phosphorylcholine (platelet activating factor), Biochem. Biophys. Acta, 663:222–229.PubMedCrossRefGoogle Scholar
  17. 17.
    Vargaftig, B.B., and Benveniste, J., 1983, Platelet-activating factor today, Trends Pharmacol. Sci., 4:341–344.CrossRefGoogle Scholar
  18. 18.
    Vargaftig, B.B., Chignard, M., Benveniste, J., Lefort, J., and Wal, F., 1981, Background and present status of research on platelet-activating factor (PAF-acether), Ann. N. Y. Acad. Sci., 370:119–137.PubMedCrossRefGoogle Scholar
  19. 19.
    Vargaftig, B.B., Lefort, J., Chignard, M., and Benveniste, J., 1980, Platelet-activating factor induces a platelet-dependent broncho-constriction unrelated to the formation of prostaglandin derivatives, Eur. J. Pharmac., 65:185–192.CrossRefGoogle Scholar
  20. 20.
    Young, J.M., Maloney, P.J., Jobb, S.N., and Clark, J.S., 1985, Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse, Prostaglandins, 30:545–551.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Michio Kurachi
    • 1
  • Kayoko Hongoh
    • 1
  • Akiko Watanabe
    • 1
  • Hironaka Aihara
    • 1
  1. 1.Research CenterTaisho Pharmaceutical Co., Ltd.Ohmiya, Saitama 330Japan

Personalised recommendations